Stock A214330 KUMHO HT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Kumho HT, Inc.

Equities

A214330

KR7214330003

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-07-04 EDT 		5-day change 1st Jan Change
556 KRW -0.71% Intraday chart for Kumho HT, Inc. -4.14% -13.12%
04-18 Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 19.0999977 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD. CI
01-25 Hwail Pharmaceutical Co.,Ltd. announced extension to the offering period CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 19.0999977 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD.
CI
Hwail Pharmaceutical Co.,Ltd. announced extension to the offering period
CI
Kumho HT, Inc announced that it has received KRW 4.99999955 billion in funding from Eco Volt Co.,Ltd.
CI
An unknown buyer cancelled the acquisition of 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc.
CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 25.999996662 billion in funding from Osung Advanced Materials Co., Ltd., Kumho HT, Inc., CrystalGenomics Invites Co., LTD.
CI
Kumho HT, Inc Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
An unknown buyer agreed to acquire approximately 2.40% stake in CrystalGenomics, Inc. from Kumho HT, Inc for KRW 28 billion.
CI
Kumho HT, Inc's Equity Buyback announced on September 28, 2022 has expired with 6,260,000 shares, representing 3.29% for KRW 6,814.16 million.
CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.
CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.
CI
Tranche Update on Kumho HT, Inc's Equity Buyback Plan announced on September 28, 2022.
CI
Kumho HT, Inc announced that it has received KRW 8.7 billion in funding from BH Co., Ltd.
CI
Kumho HT, Inc announced that it expects to receive KRW 10 billion in funding from BH Co., Ltd.
CI
Kumho HT, Inc announces an Equity Buyback for KRW 7,000 million worth of its shares.
CI
Kumho HT, Inc authorizes a Buyback Plan.
CI
CrystalGenomics, Inc. announced that it has received KRW 5.7075 billion in funding from Kumho HT, Inc
CI
CrystalGenomics, Inc. announced that it expects to receive KRW 5.7075 billion in funding from Kumho HT, Inc
CI
Kumho HT, Inc announced a financing transaction
CI
An unknown buyer agreed to acquire approximately 16.5% stake in DiNonA Inc. from Kumho HT, Inc for KRW 19.9 billion.
CI
Kumho HT, Inc. completed the acquisition of remaining 81% stake in DiNonA Inc..
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A214330 Stock
  4. News Kumho HT, Inc.